To gain further insight, we performed transcriptome sequencing on several AML and ALL cell lines and primary samples, which revealed higher expression of inhibitory ligands/receptors, including B7-H3, TIM3, and CD155 in AML cell lines and primary samples (Fig. 3A). The gene discussed is CD276; the disease is acute lymphoblastic leukemia.